Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment
Authors
Keywords
-
Journal
CURRENT MEDICAL RESEARCH AND OPINION
Volume -, Issue -, Pages 1-14
Publisher
Informa UK Limited
Online
2018-07-26
DOI
10.1080/03007995.2018.1505352
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population
- (2017) Marjan Kerkhof et al. THORAX
- Effect of Anti–IL-13 Treatment on Airway Dimensions in Severe Asthma
- (2016) Christopher E. Brightling et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria
- (2016) M. Hew et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study
- (2016) Njira Lugogo et al. CLINICAL THERAPEUTICS
- Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry
- (2016) P. G. Gibson et al. INTERNAL MEDICINE JOURNAL
- A Phase 2a Study of Benralizumab for Patients with Eosinophilic Asthma in South Korea and Japan
- (2016) Hae-Sim Park et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Factors affecting ability to achieve asthma control in adult patients with moderate to severe persistent asthma
- (2016) Lyne Scott et al. JOURNAL OF ASTHMA
- Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
- (2016) Eugene R Bleecker et al. LANCET
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial
- (2016) Sally Wenzel et al. LANCET
- Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
- (2016) J Mark FitzGerald et al. LANCET
- Effects of older age and age of asthma onset on clinical and inflammatory variables in severe refractory asthma
- (2016) Rekha Chaudhuri et al. RESPIRATORY MEDICINE
- Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status
- (2016) Huib A.M. Kerstjens et al. RESPIRATORY MEDICINE
- Profile of difficult to treat asthma patients referred for systematic assessment
- (2016) N. Radhakrishna et al. RESPIRATORY MEDICINE
- Omalizumab Improves Quality of Life and Asthma Control in Chinese Patients With Moderate to Severe Asthma: A Randomized Phase III Study
- (2016) Jing Li et al. Allergy Asthma & Immunology Research
- Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)
- (2016) Robert M Niven et al. BMJ Open
- Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma
- (2016) Nestor A Molfino et al. BMJ Open
- Asthma-related deaths
- (2016) Gennaro D’Amato et al. MULTIDISCIPLINARY RESPIRATORY MEDICINE
- Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial
- (2016) Paul M O'Byrne et al. Lancet Respiratory Medicine
- Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
- (2016) Nicola A Hanania et al. Lancet Respiratory Medicine
- Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies
- (2016) Hector G Ortega et al. Lancet Respiratory Medicine
- Utilization and Costs of Severe Uncontrolled Asthma in a Managed-Care Setting
- (2016) Robert S. Zeiger et al. Journal of Allergy and Clinical Immunology-In Practice
- Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting
- (2016) Benjamin Chastek et al. Journal of Managed Care & Specialty Pharmacy
- Direct Health Care Costs Associated with Asthma in British Columbia
- (2016) Mohsen Sadatsafavi et al. Canadian Respiratory Journal
- Real life study of three years omalizumab in patients with difficult-to-control asthma
- (2015) J. Jesús López Tiro et al. ALLERGOLOGIA ET IMMUNOPATHOLOGIA
- Changes in asthma control, work productivity, and impairment with omalizumab: 5-year EXCELS study results
- (2015) James L. Zazzali et al. ALLERGY AND ASTHMA PROCEEDINGS
- Omalizumab adherence in an observational study of patients with moderate to severe allergic asthma
- (2015) Susan L. Janson et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Outcomes before and after treatment escalation to Global Initiative for Asthma steps 4 and 5 in severe asthma
- (2015) Patrick W. Sullivan et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort
- (2015) Dominick E. Shaw et al. EUROPEAN RESPIRATORY JOURNAL
- Acute and chronic systemic corticosteroid–related complications in patients with severe asthma
- (2015) Patrick Lefebvre et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The prevalence of severe refractory asthma
- (2015) Pieter-Paul W. Hekking et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Characterizing the severe asthma population in the United States: claims-based analysis of three treatment cohorts in the year prior to treatment escalation
- (2015) Patrick W. Sullivan et al. JOURNAL OF ASTHMA
- Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy
- (2015) Federica Novelli et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Influence of upper airway abnormalities on the control of severe asthma: a cross-sectional study
- (2015) Francisco Soares Nascimento-Sampaio et al. International Forum of Allergy & Rhinology
- Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials
- (2015) Mario Castro et al. Lancet Respiratory Medicine
- Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study
- (2015) David B Price et al. Lancet Respiratory Medicine
- Budesonide/formoterol maintenance and reliever therapy in moderate-to-severe asthma: Effects on eosinophilic airway inflammation
- (2014) Kiyoshi Takeyama et al. ALLERGY AND ASTHMA PROCEEDINGS
- Comprehensive efficacy of omalizumab for severe refractory asthma: a time-series observational study
- (2014) Tomoko Tajiri et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Factores asociados con el asma grave no controlada y con la percepción del control por parte de médicos y pacientes
- (2014) María del Carmen Vennera et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Tiotropium may improve asthma symptoms and lung function in asthmatic patients with irreversible airway obstruction: the real-life data
- (2014) Oznur Abadoglu et al. Clinical Respiratory Journal
- Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation
- (2014) G Norman et al. HEALTH TECHNOLOGY ASSESSMENT
- Risk factors for death in patients with severe asthma
- (2014) Andréia Guedes Oliva Fernandes et al. Jornal Brasileiro de Pneumologia
- Efficacy and safety of an anti–IL-13 mAb in patients with severe asthma: A randomized trial
- (2014) Erika H. De Boever et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Continuous terbutaline infusion in severe asthma in adults: a retrospective study of long-term efficacy and safety
- (2014) Adel H. Mansur et al. JOURNAL OF ASTHMA
- Omalizumab management beyond clinical trials: The added value of a network model
- (2014) Marco Caminati et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma control
- (2014) M. Molimard et al. RESPIRATORY MEDICINE
- Experiência clínica com omalizumab na consulta de asma grave
- (2014) S. Alfarroba et al. Revista Portuguesa de Pneumologia
- The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry
- (2014) S. O'Neill et al. THORAX
- Impact of Omalizumab On All-Cause and Asthma-Related Health Care Resource Utilisation in Patients With Moderate or Severe Persistent Asthma
- (2014) S.J. Turner et al. VALUE IN HEALTH
- Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study
- (2014) Mario Castro et al. Lancet Respiratory Medicine
- Asthma Exacerbation Rates in Adults Are Unchanged Over a 5-Year Period Despite High-Intensity Therapy
- (2014) Michael Schatz et al. Journal of Allergy and Clinical Immunology-In Practice
- The Prevalence of Severe Asthma and Low Asthma Control Among Danish Adults
- (2014) Anna von Bülow et al. Journal of Allergy and Clinical Immunology-In Practice
- Clinical Burden and Predictors of Asthma Exacerbations in Patients on Guideline-based Steps 4-6 Asthma Therapy in the TENOR Cohort
- (2014) William J. Calhoun et al. Journal of Allergy and Clinical Immunology-In Practice
- Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy
- (2013) Nicola A. Hanania et al. ANNALS OF INTERNAL MEDICINE
- Does Omalizumab Make a Difference to the Real-life Treatment of Asthma Exacerbations?
- (2013) Lamiae Grimaldi-Bensouda et al. CHEST
- A Proof-of-Concept, Randomized, Controlled Trial of Omalizumab in Patients With Severe, Difficult-to-Control, Nonatopic Asthma
- (2013) Gilles Garcia et al. CHEST
- The Effect of Omalizumab in Treatment of Inadequate Controlled Severe Persistent Asthma Patient
- (2013) Mohamed Zakaria et al. CHEST
- Immunogenicity and safety of omalizumab in pre-filled syringes in patients with allergic (IgE-mediated) asthma
- (2013) Laura Somerville et al. CURRENT MEDICAL RESEARCH AND OPINION
- International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
- (2013) K. F. Chung et al. EUROPEAN RESPIRATORY JOURNAL
- Severe adult-onset asthma: A distinct phenotype
- (2013) Marijke Amelink et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Assessment of Long-term Omalizumab Treatment in Patients with Severe Allergic Asthma Long-term Omalizumab Treatment in Severe Asthma
- (2013) Eylem Sercan Özgür et al. JOURNAL OF ASTHMA
- Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
- (2013) Sally Wenzel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A study into efficacy of omalizumab therapy in patients with severe persistent allergic asthma at a tertiary referral centre for asthma in Ireland
- (2013) A. Subramaniam et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Phenotypic predictors of response to oral glucocorticosteroids in severe asthma
- (2013) Maciej Kupczyk et al. RESPIRATORY MEDICINE
- Health status measurement in patients with severe asthma
- (2013) Jeannette B. Peters et al. RESPIRATORY MEDICINE
- Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial
- (2013) Guy G Brusselle et al. THORAX
- Estimating The Budget Impact Of Adding Omalizumab To Standard Therapy In Patients With Uncontrolled Severe Allergic Asthma From Private Health Care System Perspective In Brazil
- (2013) C. Suzuki et al. VALUE IN HEALTH
- Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force
- (2013) Sean D. Sullivan et al. VALUE IN HEALTH
- Predictors for Identifying the Efficacy of Systemic Steroids on Sustained Exhaled Nitric Oxide Elevation in Severe Asthma
- (2013) Kazuto Matsunaga et al. ALLERGOLOGY INTERNATIONAL
- Profile of patients treated with omalizumab in routine clinical practice in Spain
- (2012) J. Ancochea et al. ALLERGOLOGIA ET IMMUNOPATHOLOGIA
- Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma
- (2012) Marie-Hélène Lafeuille et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Airway impedance entropy and exacerbations in severe asthma
- (2012) Sherif Gonem et al. EUROPEAN RESPIRATORY JOURNAL
- Comparação entre dois métodos de avaliação do controle da asma baseados na percepção individual
- (2012) Paula Cristina Andrade Almeida et al. Jornal Brasileiro de Pneumologia
- Specific IgE against Staphylococcus aureus enterotoxins: An independent risk factor for asthma
- (2012) Claus Bachert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Effect of Omalizumab as Add-On Therapy on Asthma-Related Quality of Life in Severe Allergic Asthma: A Brazilian Study (QUALITX)
- (2012) A.S Rubin et al. JOURNAL OF ASTHMA
- A 26-Week, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Effect of Omalizumab on Asthma Control in Patients with Persistent Allergic Asthma
- (2012) Jose Bardelas et al. JOURNAL OF ASTHMA
- Omalizumab Therapy in Severe Asthma: Experience from the Spanish Registry—Some New Approaches
- (2012) María Del Carmen Vennera et al. JOURNAL OF ASTHMA
- A 36-Month Study on the Cost/Utility of Add-On Omalizumab in Persistent Difficult-to-Treat Atopic Asthma in Italy
- (2012) Roberto Walter Dal Negro et al. JOURNAL OF ASTHMA
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
- (2012) Ian D Pavord et al. LANCET
- Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy
- (2012) Huib A.M. Kerstjens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Adding Omalizumab, an Anti-Immunoglobulin E Antibody, on Airway Wall Thickening in Asthma
- (2012) Makoto Hoshino et al. RESPIRATION
- Monitoring free serum IgE in severe asthma patients treated with omalizumab
- (2012) Stephanie Korn et al. RESPIRATORY MEDICINE
- Natural history and risk factors of obstructive changes over a 10-year period in severe asthma
- (2012) Kazuto Matsunaga et al. RESPIRATORY MEDICINE
- Oestrogen induces mucoid conversion ofPseudomonas Aeruginosain women with cystic fibrosis, and increases exacerbations
- (2012) Gemma Hayes THORAX
- Cost-effectiveness of omalizumab for uncontrolled allergic asthma in the Netherlands
- (2012) Floortje van Nooten et al. JOURNAL OF MEDICAL ECONOMICS
- Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma
- (2011) J. Bousquet et al. ALLERGY
- Reslizumab for Poorly Controlled, Eosinophilic Asthma
- (2011) Mario Castro et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Prospective evaluation of current asthma control using ACQ and ACT compared with GINA criteria
- (2011) Stephanie Korn et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Persistence of Community-Acquired Respiratory Distress Syndrome Toxin-Producing Mycoplasma pneumoniae in Refractory Asthma
- (2011) Jay Peters et al. CHEST
- Omalizumab in patients with severe asthma: the XCLUSIVE study
- (2011) Christian Schumann et al. Clinical Respiratory Journal
- Tiotropium improves lung function in patients with severe uncontrolled asthma: A randomized controlled trial
- (2011) Huib A.M. Kerstjens et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Economic Costs for Adult Asthmatics According to Severity and Control Status in Korean Tertiary Hospitals
- (2011) Sae-Hoon Kim et al. JOURNAL OF ASTHMA
- Omalizumab Reduces Corticosteroid Use in Patients with Severe Allergic Asthma: Real-Life Experience in Israel
- (2011) Menachem Rottem JOURNAL OF ASTHMA
- Concomitant Asthma Medication Use in Patients Receiving Omalizumab: Results from Three Large Insurance Claims Databases
- (2011) Marie-Hélène Lafeuille et al. JOURNAL OF ASTHMA
- Changes in Total IgE Plasma Concentration Measured at the Third Month during Anti-IgE Treatment Predict Future Exacerbation Rates in Difficult-to-Treat Atopic Asthma: A Pilot Study
- (2011) Roberto W. Dal Negro et al. JOURNAL OF ASTHMA
- Long-term omalizumab treatment in severe allergic asthma: The South-Eastern Mediterranean “real-life” experience
- (2011) Eleni G. Tzortzaki et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- A study of a multi-level intervention to improve non-adherence in difficult to control asthma
- (2011) Jacqueline Gamble et al. RESPIRATORY MEDICINE
- Clinical characteristics and possible phenotypes of an adult severe asthma population
- (2011) Regina Maria de Carvalho-Pinto et al. RESPIRATORY MEDICINE
- Real-life prospective study on asthma control in Italy: Cross-sectional phase results
- (2011) Luigi Allegra et al. RESPIRATORY MEDICINE
- Role of neutrophils in persistent airway obstruction due to refractory asthma
- (2011) JAE-SUNG CHOI et al. RESPIROLOGY
- Internet-based tapering of oral corticosteroids in severe asthma: a pragmatic randomised controlled trial
- (2011) S. Hashimoto et al. THORAX
- Care of asthma patients in relation to guidelines
- (2010) Michael S. Broder et al. ALLERGY AND ASTHMA PROCEEDINGS
- Symptoms, spirometry, exhaled nitric oxide, and asthma exacerbations in clinical practice
- (2010) Daniel Menzies et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Insurance status and asthma-related health care utilization in patients with severe asthma
- (2010) Anju T. Peters et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Effects of oral prednisone on sputum eosinophils and cytokines in patients with severe refractory asthma
- (2010) Federico L. Dente et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Effectiveness of omalizumab in patients 50 years and older with severe persistent allergic asthma
- (2010) Stephanie Korn et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Health experiences of adolescents with uncontrolled severe asthma
- (2010) K. Edgecombe et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Relación entre presencia de comorbilidad y control del asma
- (2010) Luis Alejandro Pérez De Llano et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Insights into severe asthma control as assessed by guidelines, pulmonologist, patient, and partner
- (2010) Mathieu Molimard et al. JOURNAL OF ASTHMA
- Factors Associated With the Control of Severe Asthma
- (2010) Juan Luis Rodriguez Hermosa et al. JOURNAL OF ASTHMA
- Italian real-life experience of omalizumab
- (2010) M. Cazzola et al. RESPIRATORY MEDICINE
- Omalizumab-induced decrease of FcɛRI expression in patients with severe allergic asthma
- (2010) Pascal Chanez et al. RESPIRATORY MEDICINE
- Phénotype des patients asthmatiques selon le score dérivé de l’Asthma Control Test®
- (2010) P. Godard et al. REVUE DES MALADIES RESPIRATOIRES
- Increased levels of osteopontin in sputum supernatant in severe refractory asthma
- (2010) V. Delimpoura et al. THORAX
- Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics
- (2009) M. Humbert et al. ALLERGY
- A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-α Blockade in Severe Persistent Asthma
- (2009) Sally E. Wenzel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Prevalence of Nonadherence in Difficult Asthma
- (2009) Jacqueline Gamble et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Factors associated with uncontrolled asthma in Porto Alegre, Brazil
- (2009) P.T.R. Dalcin et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma
- (2009) L. A. Perez-de-Llano et al. EUROPEAN RESPIRATORY JOURNAL
- Prevalence of obstructive sleep apnea–hypopnea in severe versus moderate asthma
- (2009) Joanne Y. Julien et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Phenotypic determinants of uncontrolled asthma
- (2009) Valérie Siroux et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
- (2009) Pranabashis Haldar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany
- (2009) S. Korn et al. RESPIRATORY MEDICINE
- “Real-life” effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study
- (2009) G. Brusselle et al. RESPIRATORY MEDICINE
- The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use
- (2009) Stephanie C. Manson et al. RESPIRATORY MEDICINE
- Economic burden of asthma: a systematic review
- (2009) Katayoun Bahadori et al. BMC Pulmonary Medicine
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- The impact of GINA suggested drugs for the treatment of asthma on Health-Related Quality of Life: a GA2LEN review
- (2008) I. Baiardini et al. ALLERGY
- A breath for health: an exploratory study in severe asthma patients in Turkey
- (2008) S. Bavbek et al. ALLERGY
- Airway inflammation in obese and nonobese patients with difficult-to-treat asthma
- (2008) I. H. van Veen et al. ALLERGY
- Omalizumab therapy: patients who achieve greatest benefit for their asthma experience greatest benefit for rhinitis
- (2008) M. Humbert et al. ALLERGY
- Extent of uncontrolled disease and associated medical costs in severe asthma – a PHARMO study
- (2008) Nancy S. Breekveldt-Postma et al. CURRENT MEDICAL RESEARCH AND OPINION
- Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: An open-label study
- (2008) R. Niven et al. RESPIRATORY MEDICINE
- High-sensitivity C-reactive protein in the exhaled breath condensate and serum in stable and unstable asthma
- (2008) Ziemowit Zietkowski et al. RESPIRATORY MEDICINE
- The role of a soluble TNF receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial
- (2008) J B Morjaria et al. THORAX
- Effectiveness of omalizumab (Xolair®) in the first patients treated in real-life practice in France
- (2007) Mathieu Molimard et al. RESPIRATORY MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More